3eej: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3eej.png|left|200px]] | |||
[[Image:3eej. | |||
{{STRUCTURE_3eej| PDB=3eej | SCENE= }} | {{STRUCTURE_3eej| PDB=3eej | SCENE= }} | ||
===Candida glabrata Dihydrofolate Reductase complexed with 2,4-diamino-5-[3-methyl-3-(3-methoxy-5-phenylphenyl)prop-1-ynyl]-6-methylpyrimidine(UCP111D) and NADPH=== | ===Candida glabrata Dihydrofolate Reductase complexed with 2,4-diamino-5-[3-methyl-3-(3-methoxy-5-phenylphenyl)prop-1-ynyl]-6-methylpyrimidine(UCP111D) and NADPH=== | ||
{{ABSTRACT_PUBMED_19152636}} | {{ABSTRACT_PUBMED_19152636}} | ||
==About this Structure== | ==About this Structure== | ||
[[3eej]] is a 2 chain structure of [[Dihydrofolate reductase]] with sequence from [http://en.wikipedia.org/wiki/Candida_glabrata Candida glabrata]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EEJ OCA]. | |||
==See Also== | |||
*[[Dihydrofolate reductase|Dihydrofolate reductase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019152636</ref><references group="xtra"/> | ||
[[Category: Candida glabrata]] | [[Category: Candida glabrata]] | ||
[[Category: Anderson, A.]] | [[Category: Anderson, A.]] | ||
| Line 29: | Line 20: | ||
[[Category: Enzyme]] | [[Category: Enzyme]] | ||
[[Category: Oxidoreductase]] | [[Category: Oxidoreductase]] | ||
Revision as of 09:50, 27 July 2012
Candida glabrata Dihydrofolate Reductase complexed with 2,4-diamino-5-[3-methyl-3-(3-methoxy-5-phenylphenyl)prop-1-ynyl]-6-methylpyrimidine(UCP111D) and NADPH
Template:ABSTRACT PUBMED 19152636
About this Structure
3eej is a 2 chain structure of Dihydrofolate reductase with sequence from Candida glabrata. Full crystallographic information is available from OCA.
See Also
Reference
- Liu J, Bolstad DB, Smith AE, Priestley ND, Wright DL, Anderson AC. Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors. Chem Biol Drug Des. 2009 Jan;73(1):62-74. PMID:19152636 doi:10.1111/j.1747-0285.2008.00745.x